文献速递妇产影像MR

基于多序列MRI影像组学模型预测子宫内膜癌患者POLE突变状态

Multisequence MRI-based radiomics model for predicting POLE mutation status in patients with endometrial cancer.
PubMed 文献 · Br J Radiol · 2023-09-03

回顾性纳入138例病理确诊子宫内膜癌患者(35例POLE突变型 vs 103例非POLE突变型),基于轴位脂肪抑制T2WI、DWI和CE-T1WI构建三个单序列影像组学标签,并进一步建立T2WI+DWI和T2WI+DWI+CE-T1WI两个多序列逻辑回归模型。整合三序列特征的RM2表现最佳,训练集AUC 0.885(95%CI: 0.828-0.942),验证集AUC 0.810(95%CI: 0.653-0.967)。NRI和IDI分析提示RM2较单序列标签和RM1在预测POLE突变状态上有改善,校准曲线、决策曲线和临床影响曲线提示RM2校准良好且具有临床实用性。

要点

  • 基于T2WI+DWI+CE-T1WI三序列融合的RM2模型预测POLE突变状态表现最佳,训练集AUC 0.885、验证集AUC 0.810。
  • RM2较单序列影像组学标签及T2WI+DWI模型RM1在预测POLE突变状态上有改善(NRI和IDI分析)。
  • 该模型为无创、经济地术前识别POLE突变型子宫内膜癌提供了潜在工具。

核心结论

  • 融合三序列特征的RM2模型可能成为无创术前识别POLE突变型子宫内膜癌的潜在工具,有助于制定个体化治疗策略。

研究设计与样本

  • 回顾性研究,纳入138例病理确诊子宫内膜癌患者(35例POLE突变型 vs 103例非POLE突变型),基于轴位脂肪抑制T2WI、DWI和CE-T1WI提取特征并构建影像组学标签与逻辑回归模型。

诊断标准与关键数值

  • RM2(整合T2WI、DWI、CE-T1WI三序列特征)训练集AUC 0.885(95%CI: 0.828-0.942),验证集AUC 0.810(95%CI: 0.653-0.967)。
  • NRI和IDI分析提示RM2较单序列影像组学标签和RM1在预测POLE突变状态上有改善。
  • 校准曲线、决策曲线分析和临床影响曲线提示RM2校准良好且具有临床实用性。

临床应用与阅片要点

  • 作者认为RM2融合三序列特征,可能作为无创术前识别POLE突变型子宫内膜癌的潜在工具,有助于制定个体化治疗策略。
  • 作者认为该研究开发了POLE测序的潜在替代方法,具有成本效益且无创。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Preoperative identification of POLE mutation status would help tailor the surgical procedure and adjuvant treatment strategy. This study aimed to explore the feasibility of developing a radiomics model to pre-operatively predict the pathogenic POLE mutation status in patients with EC.

METHODS: The retrospective study involved 138 patients with histopathologically confirmed EC (35 POLE-mutant vs 103 non-POLE-mutant). After selecting relevant features with a series of steps, three radiomics signatures were built based on axial fat-saturation T2WI, DWI, and CE-T1WI images, respectively. Then, two radiomics models which integrated features from T2WI + DWI and T2WI + DWI+CE-T1WI were further developed using multivariate logistic regression. The performance of the radiomics model was evaluated from discrimination, calibration, and clinical utility aspects.

RESULTS: Among all the models, radiomics model2 (RM2), which integrated features from all three sequences, showed the best performance, with AUCs of 0.885 (95%CI: 0.828-0.942) and 0.810 (95%CI: 0.653-0.967) in the training and validation cohorts, respectively. The net reclassification index (NRI) and integrated discrimination improvement (IDI) analyses indicated that RM2 had improvement in predicting POLE mutation status when compared with the single-sequence-based signatures and the radiomics model1 (RM1). The calibration curve, decision curve analysis, and clinical impact curve suggested favourable calibration and clinical utility of RM2.

CONCLUSIONS: The RM2, fusing features from three sequences, could be a potential tool for the non-invasive preoperative identification of patients with POLE-mutant EC, which is helpful for developing individualized therapeutic strategies.

ADVANCES IN KNOWLEDGE: This study developed a potential surrogate of POLE sequencing, which is cost-efficient and non-invasive.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Lin Z, Gu W, Guo Q, et al. Multisequence MRI-based radiomics model for predicting POLE mutation status in patients with endometrial cancer. Br J Radiol. 2023. PMID: 37660398. doi:10.1259/bjr.20221063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。